{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T13:53:56Z","timestamp":1766152436402,"version":"3.48.0"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100018255","name":"GLA University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100018255","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Computational Biology and Chemistry"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.compbiolchem.2025.108733","type":"journal-article","created":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T23:18:25Z","timestamp":1760656705000},"page":"108733","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"P1","title":["Distinct signatures of molecular recognition of AXL kinase by varied classes of inhibitors examined through biomolecular simulations"],"prefix":"10.1016","volume":"120","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-6147-3516","authenticated-orcid":false,"given":"Suman","family":"Sinha","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-5478-626X","authenticated-orcid":false,"given":"Ram","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-6607-0683","authenticated-orcid":false,"given":"Km","family":"Shainda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.compbiolchem.2025.108733_bib1","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.softx.2015.06.001","article-title":"GROMACS: high performance molecular simulations through multi-level parallelism from laptops to supercomputers","volume":"1-2","author":"Abraham","year":"2015","journal-title":"SoftwareX"},{"key":"10.1016\/j.compbiolchem.2025.108733_bib2","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1038\/s41573-021-00252-y","article-title":"Trends in kinase drug discovery: targets, indications and inhibitor design","volume":"20","author":"Attwood","year":"2021","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.compbiolchem.2025.108733_bib3","doi-asserted-by":"crossref","DOI":"10.1103\/PhysRevLett.100.020603","article-title":"Well-tempered metadynamics: a smoothly converging and tunable free-energy method","volume":"100","author":"Barducci","year":"2008","journal-title":"Phys. Rev. Lett."},{"key":"10.1016\/j.compbiolchem.2025.108733_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.lungcan.2023.107291","article-title":"Phase 1 trial of bemcentinib (BGB324), a first-in-class, selective AXL inhibitor, with docetaxel in patients with previously treated advanced non-small cell lung cancer","volume":"182","author":"Bhalla","year":"2023","journal-title":"Lung Cancer"},{"key":"10.1016\/j.compbiolchem.2025.108733_bib5","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1016\/j.cpc.2009.05.011","article-title":"PLUMED: a portable plugin for free-energy calculations with molecular dynamics","volume":"180","author":"Bonomi","year":"2009","journal-title":"Comput. Phys. Commun."},{"issue":"1","key":"10.1016\/j.compbiolchem.2025.108733_bib6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13321-021-00548-6","article-title":"ProLIF: a library to encode molecular interactions as fingerprints","volume":"13","author":"Bouysset","year":"2021","journal-title":"Journal of Cheminformatics"},{"key":"10.1016\/j.compbiolchem.2025.108733_bib7","doi-asserted-by":"crossref","DOI":"10.1063\/1.2408420","article-title":"Canonical sampling through velocity rescaling","volume":"126","author":"Bussi","year":"2007","journal-title":"J. Chem. Phys."},{"key":"10.1016\/j.compbiolchem.2025.108733_bib8","first-page":"145","article-title":"Preclinical development of mecbotamab vedotin (BA3011), a novel, AXL-specific conditional active biologic antibody\u2013drug conjugate","volume":"8","author":"Chang","year":"2025","journal-title":"Antib. Ther."},{"key":"10.1016\/j.compbiolchem.2025.108733_bib9","doi-asserted-by":"crossref","DOI":"10.14814\/phy2.15140","article-title":"AXL targeting by a specific small molecule or monoclonal antibody inhibits renal cell carcinoma progression in an orthotopic mice model","volume":"9","author":"Chen","year":"2021","journal-title":"Physiol. Rep."},{"key":"10.1016\/j.compbiolchem.2025.108733_bib10","doi-asserted-by":"crossref","first-page":"201","DOI":"10.3390\/biomedicines12010201","article-title":"Anticancer drug discovery based on natural products: from computational approaches to clinical studies","volume":"12","author":"Chunarkar-Patil","year":"2024","journal-title":"Biomedicines"},{"key":"10.1016\/j.compbiolchem.2025.108733_bib11","doi-asserted-by":"crossref","DOI":"10.1063\/1.2779878","article-title":"On the calculation of velocity-dependent properties in molecular dynamics simulations using the leapfrog integration algorithm","volume":"127","author":"Cuendet","year":"2007","journal-title":"J. Chem. Phys."},{"key":"10.1016\/j.compbiolchem.2025.108733_bib12","doi-asserted-by":"crossref","first-page":"10089","DOI":"10.1063\/1.464397","article-title":"Particle mesh ewald: an N\u22c5log(N) method for ewald sums in large systems","volume":"98","author":"Darden","year":"1993","journal-title":"J. Chem. Phys."},{"key":"10.1016\/j.compbiolchem.2025.108733_bib13","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1063\/1.1376628","article-title":"Comparison of thermostatting mechanisms in NVT and NPT simulations of decane under shear","volume":"115","author":"Delhommelle","year":"2001","journal-title":"J. Chem. Phys."},{"key":"10.1016\/j.compbiolchem.2025.108733_bib14","doi-asserted-by":"crossref","DOI":"10.1158\/0008-5472.CAN-24-3841","article-title":"AXL tyrosine kinases: a growing isoform family that promotes cancer pathogenesis","author":"Eriksen Gjerstad","year":"2025","journal-title":"Cancer Res."},{"key":"10.1016\/j.compbiolchem.2025.108733_bib15","doi-asserted-by":"crossref","first-page":"15705","DOI":"10.1074\/jbc.M116.771485","article-title":"The axl kinase domain in complex with a macrocyclic inhibitor offers first structural insights into an active TAM receptor kinase","volume":"292","author":"Gajiwala","year":"2017","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.compbiolchem.2025.108733_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.molliq.2022.118901","article-title":"Molecular dynamics simulation approach for discovering potential inhibitors against SARS-CoV-2: a structural review","volume":"354","author":"Ghahremanian","year":"2022","journal-title":"J. Mol. Liq."},{"key":"10.1016\/j.compbiolchem.2025.108733_bib17","article-title":"MDAnalysis: A Python Package for the Rapid Analysis of Molecular Dynamics Simulations","author":"Gowers","year":"2019","journal-title":"Proceedings of the 15th Python in Science Conference"},{"issue":"12","key":"10.1016\/j.compbiolchem.2025.108733_bib18","doi-asserted-by":"crossref","first-page":"4334","DOI":"10.1080\/07391102.2020.1776157","article-title":"Identification of potential natural inhibitors of SARS-CoV2 main protease by molecular docking and simulation studies","volume":"39","author":"Gupta","year":"2021","journal-title":"Journal of Biomolecular Structure and Dynamics"},{"key":"10.1016\/j.compbiolchem.2025.108733_bib19","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.cytogfr.2006.04.004","article-title":"Signalling and functional diversity within the axl subfamily of receptor tyrosine kinases","volume":"17","author":"Hafizi","year":"2006","journal-title":"Cytokine Growth Factor Rev."},{"key":"10.1016\/j.compbiolchem.2025.108733_bib20","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1007\/BF00941484","article-title":"A steepest-descent method for optimization of mechanical systems","volume":"19","author":"Haug","year":"1976","journal-title":"J. Optim. Theory Appl."},{"key":"10.1016\/j.compbiolchem.2025.108733_bib21","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1021\/ct5010406","article-title":"Long-time-step molecular dynamics through hydrogen mass repartitioning","volume":"11","author":"Hopkins","year":"2015","journal-title":"J. Chem. Theory Comput."},{"key":"10.1016\/j.compbiolchem.2025.108733_bib22","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1002\/jcc.23354","article-title":"CHARMM36 all-atom additive protein force field: validation based on comparison to NMR data","volume":"34","author":"Huang","year":"2013","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.compbiolchem.2025.108733_bib23","doi-asserted-by":"crossref","unstructured":"Islam, R., Parves, M. R., Paul, A. S., Uddin, N., Rahman, M. S., Mamun, A. Al, Hossain, M. N., Ali, M. A., & Halim, M. A. (2021). A molecular modeling approach to identify effective antiviral phytochemicals against the main protease of SARS-CoV-2. Journal of Biomolecular Structure and Dynamics, 39(9), 3213\u20133224. https:\/\/doi.org\/10.1080\/07391102.2020.1761883.","DOI":"10.1080\/07391102.2020.1761883"},{"key":"10.1016\/j.compbiolchem.2025.108733_bib24","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14194821","article-title":"A novel selective Axl\/Mer\/CSF1R kinase inhibitor as a cancer immunotherapeutic agent targeting both immune and tumor cells in the tumor microenvironment","volume":"14","author":"Jeon","year":"2022","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.compbiolchem.2025.108733_bib25","doi-asserted-by":"crossref","first-page":"5152","DOI":"10.18632\/oncotarget.27114","article-title":"DS-1205b, a novel selective inhibitor of AXL kinase, blocks resistance to EGFR-tyrosine kinase inhibitors in a non-small cell lung cancer xenograft model","volume":"10","author":"Jimbo","year":"2019","journal-title":"Oncotarget"},{"key":"10.1016\/j.compbiolchem.2025.108733_bib26","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1002\/jcc.24660","article-title":"CHARMM-GUI 10 years for biomolecular modeling and simulation","volume":"38","author":"Jo","year":"2017","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.compbiolchem.2025.108733_bib27","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1063\/1.445869","article-title":"Comparison of simple potential functions for simulating liquid water","volume":"79","author":"Jorgensen","year":"1983","journal-title":"J. Chem. Phys."},{"issue":"4","key":"10.1016\/j.compbiolchem.2025.108733_bib28","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1016\/j.bmcl.2016.12.024","article-title":"Structure-based optimization of 1H-imidazole-2-carboxamides as Axl kinase inhibitors utilizing a Mer mutant surrogate. Bioorganic &","volume":"27","author":"Keung","year":"2017","journal-title":"Medicinal Chemistry Letters"},{"key":"10.1016\/j.compbiolchem.2025.108733_bib29","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1021\/acs.jpca.8b09082","article-title":"New method for constant- NPT molecular dynamics","volume":"123","author":"Kim","year":"2019","journal-title":"J. Phys. Chem. A"},{"key":"10.1016\/j.compbiolchem.2025.108733_bib30","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.3390\/cancers15061882","article-title":"Targeting AXL using the AVB-500 soluble receptor and through genetic knockdown inhibits bile duct cancer growth and metastasis","volume":"15","author":"Kim","year":"2023","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.compbiolchem.2025.108733_bib31","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/978-3-031-69162-1_6","article-title":"Molecular dynamics and its significance in drug discovery","author":"Kumar","year":"2024","journal-title":"Struct. Based Drug Des."},{"key":"10.1016\/j.compbiolchem.2025.108733_bib32","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1182\/blood-2016-10-745133","article-title":"Preclinical studies of gilteritinib, a next-generation FLT3 inhibitor","volume":"129","author":"Lee","year":"2017","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.compbiolchem.2025.108733_bib33","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.1002\/jcc.21787","article-title":"MDAnalysis: A toolkit for the analysis of molecular dynamics simulations","volume":"32","author":"Michaud-Agrawal","year":"2011","journal-title":"Journal of Computational Chemistry"},{"key":"10.1016\/j.compbiolchem.2025.108733_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2021.116437","article-title":"Fragment-based lead discovery of indazole-based compounds as AXL kinase inhibitors","volume":"49","author":"Ng","year":"2021","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.compbiolchem.2025.108733_bib35","doi-asserted-by":"crossref","first-page":"7182","DOI":"10.1063\/1.328693","article-title":"Polymorphic transitions in single crystals: a new molecular dynamics method","volume":"52","author":"Parrinello","year":"1981","journal-title":"J. Appl. Phys."},{"issue":"1","key":"10.1016\/j.compbiolchem.2025.108733_bib36","doi-asserted-by":"crossref","DOI":"10.1080\/14756366.2023.2295241","article-title":"Discovery of novel and potent dual-targeting AXL\/HDAC2 inhibitors for colorectal cancer treatment via structure-based pharmacophore modelling, virtual screening, and molecular docking, molecular dynamics simulation studies, and biological evaluation","volume":"39","author":"Qiao","year":"2024","journal-title":"Journal of Enzyme Inhibition and Medicinal Chemistry"},{"key":"10.1016\/j.compbiolchem.2025.108733_bib37","doi-asserted-by":"crossref","first-page":"920","DOI":"10.3389\/fchem.2019.00920","article-title":"Rational drug design of axl tyrosine kinase type I inhibitors as promising candidates against cancer","volume":"7","author":"Sarukhanyan","year":"2020","journal-title":"Front. Chem."},{"key":"10.1016\/j.compbiolchem.2025.108733_bib38","doi-asserted-by":"crossref","DOI":"10.1007\/s11912-017-0579-4","article-title":"Key roles of AXL and MER receptor tyrosine kinases in resistance to multiple anticancer therapies","volume":"19","author":"Schoumacher","year":"2017","journal-title":"Curr. Oncol. Rep."},{"key":"10.1016\/j.compbiolchem.2025.108733_bib39","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.114253","article-title":"Structure-based discovery of receptor tyrosine kinase AXL degraders with excellent anti-tumor activity by selectively degrading AXL and inducing methuosis","volume":"234","author":"Shi","year":"2022","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.compbiolchem.2025.108733_bib40","doi-asserted-by":"crossref","first-page":"6281","DOI":"10.1021\/acs.jctc.1c00645","article-title":"Gmx_MMPBSA: a new tool to perform end-state free energy calculations with GROMACS","volume":"17","author":"Vald\u00e9s-Tresanco","year":"2021","journal-title":"J. Chem. Theory Comput."},{"key":"10.1016\/j.compbiolchem.2025.108733_bib41","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1002\/jcc.20291","article-title":"GROMACS: fast, flexible, and free","volume":"26","author":"Van Der Spoel","year":"2005","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.compbiolchem.2025.108733_bib42","doi-asserted-by":"crossref","first-page":"9478","DOI":"10.1021\/acs.chemrev.9b00055","article-title":"End-Point binding free energy calculation with MM\/PBSA and MM\/GBSA: strategies and applications in drug design","volume":"119","author":"Wang","year":"2019","journal-title":"Chem. Rev."},{"key":"10.1016\/j.compbiolchem.2025.108733_bib43","article-title":"Antechamber, an accessory software package for molecular mechanical calculations","volume":"222","author":"Wang","year":"2001","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.compbiolchem.2025.108733_bib44","doi-asserted-by":"crossref","first-page":"1996","DOI":"10.1158\/0008-5472.CAN-18-2022","article-title":"Immuno-oncological efficacy of RXDX-106, a novel TAM (TYRO3, AXL, MER) family Small-Molecule kinase inhibitor","volume":"79","author":"Yokoyama","year":"2019","journal-title":"Cancer Res."},{"key":"10.1016\/j.compbiolchem.2025.108733_bib45","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12943-019-1090-3","article-title":"AXL receptor tyrosine kinase as a promising anti-cancer approach: functions, molecular mechanisms and clinical applications","volume":"18","author":"Zhu","year":"2019","journal-title":"Mol. Cancer"}],"container-title":["Computational Biology and Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1476927125003949?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1476927125003949?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T13:49:48Z","timestamp":1766152188000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1476927125003949"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":45,"alternative-id":["S1476927125003949"],"URL":"https:\/\/doi.org\/10.1016\/j.compbiolchem.2025.108733","relation":{},"ISSN":["1476-9271"],"issn-type":[{"type":"print","value":"1476-9271"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Distinct signatures of molecular recognition of AXL kinase by varied classes of inhibitors examined through biomolecular simulations","name":"articletitle","label":"Article Title"},{"value":"Computational Biology and Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.compbiolchem.2025.108733","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"108733"}}